scholarly journals 2017 HRS expert consensus statement on magnetic resonance imaging and radiation exposure in patients with cardiovascular implantable electronic devices

Heart Rhythm ◽  
2017 ◽  
Vol 14 (7) ◽  
pp. e97-e153 ◽  
Author(s):  
Julia H. Indik ◽  
J. Rod Gimbel ◽  
Haruhiko Abe ◽  
Ricardo Alkmim-Teixeira ◽  
Ulrika Birgersdotter-Green ◽  
...  
EP Europace ◽  
2008 ◽  
Vol 10 (3) ◽  
pp. 336-346 ◽  
Author(s):  
A. Roguin ◽  
J. Schwitter ◽  
C. Vahlhaus ◽  
M. Lombardi ◽  
J. Brugada ◽  
...  

Circulation ◽  
2020 ◽  
Vol 142 (Suppl_3) ◽  
Author(s):  
Garima Dahiya ◽  
Adam Wetzel ◽  
Andreas Kyvernitakis ◽  
Loretta Gevenosky ◽  
RONALD WILLIAMS ◽  
...  

Introduction: Magnetic Resonance Imaging (MRI) non-conditional cardiovascular implantable electronic devices (CIEDs) have historically restricted the use of MRI. We investigated the impact of MRI on the functional integrity of CIEDs. Methods: In this prospective, observational single-center study, we enrolled patients undergoing MRI over a 5-year period. Prior to assessing the impact of MRI on CIED integrity, we performed interrogations in sequential duplication to assess the intrinsic variability of the device. Subsequently, we performed interrogations immediately after MRI and monitored changes in device parameters and clinical events. Results: We completed 492 MRI studies, 283 (58%) in patients with permanent pacemakers (PPMs), and 209 (42%) with implantable cardioverter defibrillators (ICDs). Subsequent MRI exposures occurred in 73 of 492 (15%) encounters. Accounting for intrinsic variability in CIED lead parameters, there were no significant changes in RA, RV, or LV lead parameters after MRI, regardless of the region of scan (thoracic vs non-thoracic), type of CIED (PPMs vs ICDs) and among those with serial MRIs. When ranked for % change pre- to post-MRI, the majority of RA, RV, and LV metrics for thresholds, sensing, and impedance conformed to ≤20% change. No significant clinical adverse cardiac events or effect on device microcircuitry occurred during the study. Conclusion: Incorporating a novel reproducibility tactic, there were no clinically meaningful device parameter changes nor were there adverse clinical events during or following MRIs, suggesting the effects of MRI on non-conditional CIED integrity are far less than previously perceived.


2021 ◽  
Vol 40 (1) ◽  
pp. 41-52
Author(s):  
Ana G. Almeida ◽  
Natália António ◽  
Carla Saraiva ◽  
António Miguel Ferreira ◽  
António Hipólito Reis ◽  
...  

2019 ◽  
Vol 40 (Supplement_1) ◽  
Author(s):  
D Padmanabhan ◽  
M Farwati ◽  
A Izath ◽  
A Al-Masry ◽  
D Kella ◽  
...  

Abstract Recent guideline statements approve the performance of magnetic resonance imaging (MRI) in patients with non-conditional cardiac implantable electronic devices (CIEDs) under certain closely monitored conditions. Data from current registries may have lower power to discern changes that may occur in the CIED after the MRI. Objective We aimed to systematically review the literature to identify the adverse events and significance of changes in device function associated with performing MRI in patients with CIEDs Methods A comprehensive literature search of the databases was performed between 1980- 2017. Two independent reviewers selected studies and extracted data. A random-effects model was used for meta-analysis. Results A total of 7,422 patients underwent 8,865 MRI studies. No death occurred post MRI. Clinical adverse events were extremely rare (mostly less than 1%) and are summarized in Table 1. No significant changes in the pooled mean effect size estimate was noted for the changes in the lead parameters (pacing threshold, sensing and impedance) Binary outcomes post magnetic resonance imaging in patients with non-conditional cardiac implantable electronic devices Outcome Sample size Number of patients Rate SE LL of CI UL of CI Death 7401 0 0 0 0 0 Atrial arrhythmia 7173 10 0.001 0.0004 0.0007 0.0024 Ventricular arrhythmia 7371 9 0.0012 0.0004 0.0006 0.0022 Oversensing 4981 17 0.0034 0.0008 0.0020 0.0053 Inhibition of pacing 7371 6 0.0008 0.0003 0.0003 0.0016 Lead Failure/Generator Failure 7475/7475 2/8 0.0002/0.0011 0.0001/0.0004 0.0001/0.0005 0.0009/0.002 Power on Reset 1388 105 0.0131 0.0014 0.0107 0.0161 Did not complete scan 6851 13 0.0019 0.0005 0.0011 0.0031 Chest pain 7080 11 0.0021 0.0004 0.0008 0.0027. Lead threshold rise (>0.5v/>50%-A/V) 5076/6246 12/16 0.0024/0.0026 0.0007/0.0006 0.0013/0.0015 0.0040/0.0041 Change in Battery voltage >0.04V 7132 42 0.0061 0.0009 0.0043 0.0079 Sensing decrease >50%-A/V 5087/5834 17/9 0.0033/0.0015 0.0008/0.0005 0.0020/0.0008 0.0052/0.0028 Impedance changes >50ohms/>50% 5810 22 0.0038 0.0008 0.0024 0.0057 Rise in cardiac enzymes 1703 26 0.0152 0.0030 0.0102 0.0219 A, atrial; V, ventricular; SE, standard Error; LL, lower limit; UL, upper limit; CI, Confidence intervals. Conclusions MRI in patients with non-conditional CIEDs can be performed with high degree of safety and low rate of clinical events when performed under standardized protocols Acknowledgement/Funding None


Sign in / Sign up

Export Citation Format

Share Document